Cargando…

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis

BACKGROUND: Osteoporosis compromises bone strength and increases the risk of fractures. Zoledronate prevents loss of bone mass and reduces the risk of fractures. OBJECTIVES: To determine the efficacy and safety of zoledronate in postmenopausal women with osteopenia and osteoporosis. DESIGN AND SETTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gazoni, Fernanda Martins, Civile, Vinicius Tassoni, Atallah, Álvaro Nagib, Santos, Fânia Cristina, Trevisani, Virginia Fernandes Moça
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Paulista de Medicina - APM 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214983/ https://www.ncbi.nlm.nih.gov/pubmed/37255065 http://dx.doi.org/10.1590/1516-3180.2022.0480.R1.27032023

Ejemplares similares

COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review
por: da Rocha, Aline Pereira, et al.
Publicado: (2020)

The Gut Microbiome Is Altered in Postmenopausal Women With Osteoporosis and Osteopenia
por: Rettedal, Elizabeth A, et al.
Publicado: (2021)

SARS-CoV-2 and arbovirus infection: a rapid systematic review
por: Milby, Keilla Martins, et al.
Publicado: (2020)

Correlation of sleep quality with fatigue and disease activity among patients with primary Sjögren’s syndrome: a cross-sectional study
por: Dardin, Luciana Paula, et al.
Publicado: (2020)

Effects of Transcranial Direct Current Stimulation on Knee Osteoarthritis Pain in Elderly Subjects With Defective Endogenous Pain-Inhibitory Systems: Protocol for a Randomized Controlled Trial
por: Tavares, Daniela Regina Brandao, et al.
Publicado: (2018)

Prevalence and Predictors of Osteoporosis and Osteopenia in Postmenopausal Women of Punjab, India
por: Khinda, Rubanpal, et al.
Publicado: (2022)

SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis
por: Pyone, Zar Chi, et al.
Publicado: (2020)

Discovery and Identification of Serum Succinyl‐Proteome for Postmenopausal Women with Osteoporosis and Osteopenia
por: Zhang, Li‐li, et al.
Publicado: (2019)

Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women
por: Chao, Ma, et al.
Publicado: (2013)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Osteopenia-osteoporosis discrimination in postmenopausal women by (1)H NMR-based metabonomics
por: Pontes, T. A., et al.
Publicado: (2019)

10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea
por: Baek, Yeon-Hee, et al.
Publicado: (2021)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

Specific Bioactive Collagen Peptides in Osteopenia and Osteoporosis: Long-Term Observation in Postmenopausal Women
por: Zdzieblik, Denise, et al.
Publicado: (2021)

The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women
por: Bogacz, Anna, et al.
Publicado: (2021)

Inferring Bacterial Community Interactions and Functionalities Associated with Osteopenia and Osteoporosis in Taiwanese Postmenopausal Women
por: Kuo, Yi-Jie, et al.
Publicado: (2023)

Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid
por: Carmona, Raj, et al.
Publicado: (2009)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

Burden of Osteopenia and Osteoporosis Among Postmenopausal Women in India: A Systematic Review and Meta-Analysis
por: Anupama, D. S., et al.
Publicado: (2022)

Association of inflammatory markers with all-cause mortality and cardiovascular mortality in postmenopausal women with osteoporosis or osteopenia
por: Qu, Li, et al.
Publicado: (2023)

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate - A Case Report -
por: Seok, Hyun, et al.
Publicado: (2011)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice
por: Bonnet, Nicolas, et al.
Publicado: (2013)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Uehara, Masashi, et al.
Publicado: (2021)

Short-term efficacy and safety of zoledronate acid or denosumab in Japanese patients with postmenopausal osteoporosis
por: Nakamura, Yumejiro, et al.
Publicado: (2021)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
por: Lin, Haiqing, et al.
Publicado: (2021)

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
por: Kong, Sung Hye, et al.
Publicado: (2022)

Osteoporosis, osteopenia, and atherosclerotic vascular disease
por: Aronow, Wilbert S.
Publicado: (2011)

Osteopenia and osteoporosis associated with hyperprolactinemic antipsychotics
por: Montejo, A. L., et al.
Publicado: (2023)

Relationship between Two Panoramic Radiography Indices and Bone Mineral Density of Postmenopausal Women with Osteopenia and Osteoporosis
por: Navabi, Nader, et al.
Publicado: (2018)

Nutrient Patterns and Risk of Osteopenia in Postmenopausal Women
por: Grili, Patricia Paula da Fonseca, et al.
Publicado: (2023)

Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
por: Golmohamdi, Fateme Rostami, et al.
Publicado: (2016)

Proteomic profiling analysis of postmenopausal osteoporosis and osteopenia identifies potential proteins associated with low bone mineral density
por: Huang, Dageng, et al.
Publicado: (2020)

Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
por: Al-Bogami, Mohammed M., et al.
Publicado: (2015)

Effects of risedronate on fracture risk in postmenopausal women with osteopenia
por: Siris, E. S., et al.
Publicado: (2007)

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
por: Meadows, Eric S, et al.
Publicado: (2007)

Risk factors of pain, physical function, and health-related quality of life in elderly people with knee osteoarthritis: A cross-sectional study
por: Tavares, Daniela Regina Brandão, et al.
Publicado: (2020)

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)

Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis
por: Host, L.V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3njvcl7g5mrngo8gfk9m0ihc0m